Pfizer and partner BioNTech asked U.S. health regulators to authorize three doses of their vaccine for children under 5 years.
Pfizer Inc. and partner BioNTech SE asked U.S. health regulators to authorize three doses of their vaccine for children under 5 years.
The Pfizer PFE, -1.26% -BioNTech BNTX, -1.14% vaccine was also found to be safe and well-tolerated among the children in studies, according to the companies.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: